§ 5-405. Schedule IV

   (a) In general. -- Schedule IV consists of each controlled dangerous substance:

   (1) listed in this section;

   (2) added to Schedule IV by the Department under § 5-202(b) of this title; or

   (3) designated as a Schedule IV controlled dangerous substance by the federal government unless the Department objects under § 5-202(f) of this title.

(b) Core substances. -- Substances listed in Schedule IV include a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:

   (1) barbital;

   (2) bromazepam;

   (3) camazepam;

   (4) chloral betaine;

   (5) chloral hydrate;

   (6) ethchlorvynol;

   (7) chlordiazepoxide;

   (8) clobazam;

   (9) clonazepam;

   (10) clorazepate;

   (11) clotiazepam;

   (12) cloxazolam;

   (13) delorazepam;

   (14) diazepam;

   (15) estazolam;

   (16) ethinamate;

   (17) ethylloflazepate;

   (18) fludiazepam;

   (19) flunitrazepam;

   (20) flurazepam;

   (21) halazepam;

   (22) haloxazolam;

   (23) ketazolam;

   (24) loprazolam;

   (25) lorazepam;

   (26) lormetazepam;

   (27) mebutamate;

   (28) medazepam;

   (29) methohexital;

   (30) meprobamate;

   (31) methylphenobarbital;

   (32) nimetazepam;

   (33) nitrozepam;

   (34) nordiazepam;

   (35) oxazepam;

   (36) oxazolam;

   (37) paraldehyde;

   (38) petrichloral;

   (39) phenobarbital;

   (40) pinazepam;

   (41) prazepam;

   (42) temazepam;

   (43) tetrazepam; and

   (44) triazolam.

(c) Fenfluramine. -- Substances listed in Schedule IV include:

   (1) a material, compound, mixture, or preparation that contains fenfluramine; and

   (2) if its existence is possible:

      (i) a salt of fenfluramine;

      (ii) an optical, position, or geometric isomer of fenfluramine; and

      (iii) a salt of an isomer of fenfluramine.

(d) Stimulants. -- Substances listed in Schedule IV include a material, compound, mixture, or preparation that contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:

   (1) diethylpropion;

   (2) pemoline, including organometallic complexes and their chelates; and

   (3) phentermine.

(e) Exemptions. -- By regulation, the Department may exempt from this section a compound, mixture, or preparation that contains a depressant substance listed in subsection (b) of this section if:

   (1) the compound, mixture, or preparation contains an active medicinal ingredient that does not have a depressant effect on the central nervous system; and

   (2) the admixtures are included in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances that have a depressant effect on the central nervous system.

(f) Required factors for adding substance. -- The Department may not add a substance to Schedule IV under § 5-202 of this title unless the Department finds that:

   (1) the substance has a low potential for abuse relative to the substances listed in Schedule III;

   (2) the substance has currently accepted medical use in treatment in the United States; and

   (3) abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances in Schedule III.

HISTORY: An. Code 1957, art. 27, § 279(d); 2002, ch. 26, § 2; 2003, ch. 21, § 1; 2011, ch. 65, § 5.